- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03544216
Accommodative Relief for Uncomfortable Non-Presbyopes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University College of Optometry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Visual acuity of 20/25 or better in both eyes with habitual contact lenses
- -0.75 D or more myopic in both eyes
- -0.75 D or less astigmatism in both eyes
- Current single vision contact lens wearer who does not require a reading aid
- CLDEQ-8 score of 12 or more points with habitual contact lenses
- No history of ocular surgery or medication
- Reports digital device use of at least 3 hours per day
- No significant signs of dry eye (grade 1 or less ocular surface staining, Schirmer score of 7 mm or more, and tear break up time of 7 seconds or more in bother eyes)
- No significant binocular vision disorders in both eyes (eso or exophoria of 4 prism diopters or less at distance and near, near point of convergence of 6 mm or less, no history of strabismus or patching)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Single Vision First
Subjects in this group will receive the single vision spherical (Bausch + Lomb ULTRA®) lens for the first two weeks and be crossed over to the multifocal (Bausch + Lomb ULTRA® for Presbyopia) lens for the second two weeks.Therefore, this group will receive both study interventions.
|
The multifocal contact lens (Bausch + Lomb ULTRA® for Presbyopia) will be worn for two weeks
The single vision contact lens (Bausch + Lomb ULTRA®) will be worn for two weeks
|
|
Experimental: Multifocal first
Subjects in this group will receive the multifocal (Bausch + Lomb ULTRA® for Presbyopia) lenses for the first two weeks and be crossed over to the single vision spherical (Bausch + Lomb ULTRA®) lens for the second two weeks.
Therefore, this group will receive both study interventions.
|
The multifocal contact lens (Bausch + Lomb ULTRA® for Presbyopia) will be worn for two weeks
The single vision contact lens (Bausch + Lomb ULTRA®) will be worn for two weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) Score
Time Frame: Baseline and after 2 weeks of contact lens wear with each study lens (single vision and multifocal)
|
After wearing each lens type (single vision and multifocal) for 2 weeks, subjects will complete the CLDEQ-8, a survey that assesses symptoms of contact lens discomfort, to reports their symptoms of discomfort with each lens type. CLDEQ-8 scores with the multifocal will be compared to CLDEQ-8 scores of the single vision lens and the subjects' habitual contact lenses to determine if the multifocal improved comfort. Min-Max CLDEQ-8 range: 0-37 points Higher point values indicate more/worse symptoms |
Baseline and after 2 weeks of contact lens wear with each study lens (single vision and multifocal)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016H0382-60058303
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthenopia
-
Indonesia UniversityCompletedAsthenopiaIndonesia
-
Direction Centrale du Service de Santé des ArméesNot yet recruiting
-
Beijing Tongren HospitalCompletedMyopia | Visual FatigueChina
-
Essilor InternationalElite School of Optometry and Sankara NethralayaCompleted
-
American Optometric AssociationCompletedRefractive Errors | AsthenopiaUnited States
-
Superior UniversityActive, not recruiting
-
Tauber Eye CenterAlcon ResearchCompleted
-
University of California, DavisCompleted
-
Direction Centrale du Service de Santé des ArméesRecruiting
Clinical Trials on Multifocal Contact Lens
-
CIBA VISIONCompleted
-
University of HoustonCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Bausch & Lomb IncorporatedCompletedPresbyopiaUnited States
-
Alcon ResearchCompletedRefractive Error | Presbyopia | Myopia | Ametropia
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed